Clinical Trials

Showing trials with last updates posted in 2022.

NCT04060342 | TERMINATED | PHASE1
61 participants

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2022-08-18
Start Date:
2019-08-13
Completion:
2022-04-11
Conditions
  • Pancreatic Adenocarcinoma
  • Esophageal Adenocarcinoma
  • Esophageal Squamous Cell Carcinoma
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Triple Negative Breast Cancer
  • Castration-resistant Prostate Cancer
  • Microsatellite Stable Colorectal Cancer
  • Non-small Cell Lung Cancer
  • Small-cell Lung Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Urothelial Carcinoma
  • Renal Cell Carcinoma
  • Hepatocellular Carcinoma
Interventions
  • DRUG
No Results Yet
NCT03890900 | COMPLETED | PHASE1/PHASE2
55 participants

T2DXcel Mobile Application

Study Type:
INTERVENTIONAL
Last Updated:
2022-08-18
Start Date:
2020-03-01
Completion:
2022-07-01
Conditions
  • Diabetes Mellitus, Type 2
Interventions
  • OTHER
No Results Yet
NCT03292068 | UNKNOWN | NA
576 participants

Children Recovering From Tonsil Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2022-08-18
Start Date:
2019-01-01
Completion:
2022-09-01
Conditions
  • Tonsillitis
Interventions
  • COMBINATION_PRODUCT
  • DIETARY_SUPPLEMENT
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page